Aura Biosciences Reveals Encouraging Phase 2 Outcomes for Bel-sar as a Primary Treatment in Battling Early-Stage Choroidal Melanoma
Sep 13, 2024
Treatment Invest Information
FDA Grants Approval to Arcutis' Novel ZORYVE® Cream for Atopic Dermatitis Patients
Jul 10, 2024
FDA Approves Lilly's Kisunla™ for Early Symptomatic Alzheimer's
Jul 3, 2024
New Research Suggests Less Intensive Cancer Treatments Yield Comparable Outcomes
Jun 3, 2024
Immix Biopharma Receives EU Orphan Drug Designation for NXC-201 in Multiple Myeloma
Apr 29, 2024
SciSparc Ltd. Embarks on Transformative Phase IIb Trial for Tourette Syndrome Using THC-Based Medication
Nov 11, 2023
Pasithea Therapeutics Advances ALS Treatment with New Lead Candidate PAS-003 Targeting α5β1 Integrin
Nov 9, 2023
GH Research Advances Clinical Trials for GH001 in the Fight Against Treatment-Resistant Depression
Nov 9, 2023
PharmAla Begins Groundbreaking Observational Trial for Real-World Efficacy of MDMA Therapy
Nov 9, 2023